Print Page

Centre for the Advancement of Health Innovations

The Centre for the Advancement of Health Innovations (CAHI) is committed to greater innovation in Canada’s health care system. CAHI builds on the resources, talents, and commitment of the Conference Board of Canada and key stakeholders to make Canada a world leader in the development and commercialization of new health technologies to the social, economic and medical benefit of all Canadians.

Key Objectives

  • Advance Canada’s health innovation system on a path of global competitiveness through in-depth research and multi-stakeholder engagement;
  • Foster industry investment and performance in Canadian health innovations;
  • Help build an action plan that will give governments and industry a road-map for collaboration on common innovation and health goals;
  • Improve the health care system through greater use of new health products and services.


CAHI is led by Mr. Neil Fraser, President, Medtronic Canada Ltd. Mr. Fraser brings a wealth of experience and passion for health innovations, and he is strongly committed to advancing Canada’s global position in this area.

CAHI also benefits from the support of Dr. Calvin Stiller, Professor Emeritus at the University of Western Ontario, who acts as a Special Advisor to the Steering Committee, as past co-chair of CAHI.

CAHI’s steering committee is made up of senior executives from the following organizations:

  • AstraZeneca Canada Inc.
  • Genome Canada
  • Medtronic of Canada Ltd.
  • Merck Frosst Canada Ltd.
  • Ontario Ministry of Health and Long-Term Care
  • Stilco Corporation


In order to achieve its key objectives, CAHI seeks to:

  • Undertake and publish in-depth research and analysis;
  • Engage multi-sector, multi-stakeholder groups of leaders in policy discussions;
  • Adopt a global perspective in identifying and exploring the applicability of best practices to Canada and Canadian industries;
  • Prepare communications strategies to deliver key findings to a wide audience of leaders and decision-makers, the media, and the public.

Action Plan

What’s New

Next Meeting:
March 2–5, 2015, Palo Alto, CA
Executive Study Tour: Open Innovation and Design Thinking

“Nudging” to Change Health Behaviours (Blog, April 2014)

CETA and Changes to Canada’s Pharmaceutical Patent Regime: Too Much or Not Enough IP? (Briefing, March 2014)

How Much IP Is Enough and How Much Is Too Much? CETA and Canadian Pharma (Webinar, November 2013)

Contact Us

For more information on how you can become a member of CAHI or attend a meeting as a guest, please contact:

Deborah Fleck
Senior Manager, Executive Networks

Maggie Patterson
Network Coordinator, Public Policy